Information

Dear user, the application need JavaScript support. Please enable JavaScript in your browser.

You search for a phrase ""Delarue, R."" according to the criterion: Author


Title:
MAHOGANY: A PHASE 3 TRIAL OF ZANUBRUTINIB PLUS ANTI‐CD20 VERSUS LENALIDOMIDE PLUS RITUXIMAB IN PATIENTS WITH RELAPSED/REFRACTORY FOLLICULAR OR MARGINAL ZONE LYMPHOMA.
Authors:
Sehn, L.
Sarkozy, C.
Song, Y.
Salar, A.
Trotman, J.
Zinzani, P. L.
Zhang, J.
Zhang, W.
Fustier, P.
Delarue, R.
Nastoupil, L.
Show more
Subject Terms:
MUCOSA-associated lymphoid tissue lymphoma
RITUXIMAB
CLINICAL trials
LENALIDOMIDE
MAHOGANY
BRUTON tyrosine kinase
Source:
Hematological Oncology; Jun2023 Supplement 1, Vol. 41, p168-170, 3p
Academic Journal
Title:
The VAD chemotherapy regimen plus a G-CSF dose of 10 μg/kg is as effective and less toxic than high-dose cyclophosphamide plus a G-CSF dose of 5 μg/kg for progenitor cell mobilization: results from a monocentric study of 82 patients
Authors:
Lefrère, FAff1, ID1705308_cor1
Zohar, S
Ghez, D
Delarue, R
Audat, F
Suarez, F
Hermine, O
Damaj, G
Maillard, N
Ribeil, J A
Azagury, M
Misbahi, R
Jondeau, K
Cavazzana-Calvo, M
Dal Cortivo, L
Varet, B
Show more
Source:
Bone Marrow Transplantation: Official journal of the European Society for Blood and Marrow Transplantation. 37(8):725-729
Academic Journal

We use cookies to help identify your computer so we can tailor your user experience, track shopping basket contents and remember where you are in the order process.